{"title":"阿达木单抗治疗中至重度慢性斑块性手足牛皮癣:来自REACH的疗效和安全性,这是一项随机、安慰剂对照、双盲试验","authors":"B. Michaels, J. Q. Rosso","doi":"10.1016/J.YDER.2011.11.013","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":23900,"journal":{"name":"Yearbook of Dermatology and Dermatologic Surgery","volume":"43 1","pages":"111-113"},"PeriodicalIF":0.0000,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"7","resultStr":"{\"title\":\"Adalimumab for Treatment of Moderate to Severe Chronic Plaque Psoriasis of the Hands and Feet: Efficacy and Safety Results From REACH, a Randomized, Placebo-Controlled, Double-Blind Trial\",\"authors\":\"B. Michaels, J. Q. Rosso\",\"doi\":\"10.1016/J.YDER.2011.11.013\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":23900,\"journal\":{\"name\":\"Yearbook of Dermatology and Dermatologic Surgery\",\"volume\":\"43 1\",\"pages\":\"111-113\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2012-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"7\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Yearbook of Dermatology and Dermatologic Surgery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/J.YDER.2011.11.013\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Yearbook of Dermatology and Dermatologic Surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/J.YDER.2011.11.013","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Adalimumab for Treatment of Moderate to Severe Chronic Plaque Psoriasis of the Hands and Feet: Efficacy and Safety Results From REACH, a Randomized, Placebo-Controlled, Double-Blind Trial